Zeynep Cansu Uretmen Kagiali

Dr. Zeynep Cansu Uretmen Kagiali

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
ZKZeynep Cansu Uretmen Kagiali
Zeynep Cansu Uretmen Kagiali
ESErdem Sanal
Erdem Sanal
ÖKÖzge Karayel
Özge Karayel
APAyse Nur Polat
Ayse Nur Polat
ÖSÖzge Saatci
Özge Saatci
NONurhan Ozlu
Nurhan Ozlu
Epithelial-mesenchymal transition (EMT) is driven by complex signaling events that induce dramatic biochemical and morphological changes whereby epithelial cells are converted into cancer cells. However, the underlying molecular mechanisms remain elusive. Here, we used mass spectrometry based quantitative proteomics approach to systematically analyze the post-translational biochemical changes that drive differentiation of human mammary epithelial (HMLE) cells into mesenchymal. We identified 314 proteins out of more than 6,000 unique proteins and 871 phosphopeptides out of more than 7,000 unique phosphopeptides as differentially regulated. We found that phosphoproteome is more unstable and prone to changes during EMT compared with the proteome and multiple alterations at proteome level are not thoroughly represented by transcriptional data highlighting the necessity of proteome level analysis. We discovered cell state specific signaling pathways, such as Hippo, sphingolipid signaling, and unfolded protein response (UPR) by modeling the networks of regulated proteins and potential kinase-substrate groups. We identified two novel factors for EMT whose expression increased on EMT induction: DnaJ heat shock protein family (Hsp40) member B4 (DNAJB4) and cluster of differentiation 81 (CD81). Suppression of DNAJB4 or CD81 in mesenchymal breast cancer cells resulted in decreased cell migration in vitro and led to reduced primary tumor growth, extravasation, and lung metastasis in vivo. Overall, we performed the global proteomic and phosphoproteomic analyses of EMT, identified and validated new mRNA and/or protein level modulators of EMT. This work also provides a unique platform and resource for future studies focusing on metastasis and drug resistance. Graphical Abstract Highlights 314 proteins and 871 phosphopeptides were differentially regulated during EMT. ∼65% of regulated proteins do not change at the transcriptome level during EMT. Epithelial and mesenchymal specific kinases and their substrates were identified. DNAJB4 and CD81 were identified as novel metastasis inducers in breast cancer.

26 December 2019 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
ZKZeynep Cansu Uretmen Kagiali
Zeynep Cansu Uretmen Kagiali
NSNazan Saner
Nazan Saner
MAMehmet Akdag
Mehmet Akdag
ESErdem Sanal
Erdem Sanal
BDBeste Senem Degirmenci
Beste Senem Degirmenci
NONurhan Ozlu
Nurhan Ozlu
CLIC4 and CLIC1 are members of the well-conserved chloride intracellular channel proteins (CLICs) structurally related to glutathione-S-transferases. Here, we report new roles of CLICs in cytokinesis. At the onset of cytokinesis, CLIC4 accumulates at the cleavage furrow and later localizes to the midbody in a RhoA-dependent manner. The cell cycle–dependent localization of CLIC4 is abolished when its glutathione S-transferase activity–related residues (C35A and F37D) are mutated. Ezrin, anillin, and ALIX are identified as interaction partners of CLIC4 at the cleavage furrow and midbody. Strikingly, CLIC4 facilitates the activation of ezrin at the cleavage furrow and reciprocally inhibition of ezrin activation diminishes the translocation of CLIC4 to the cleavage furrow. Furthermore, knockouts of CLIC4and CLIC1 cause abnormal blebbing at the polar cortex and regression of the cleavage furrow at late cytokinesis leading to multinucleated cells. We conclude that CLIC4 and CLIC1 function together with ezrin where they bridge plasma membrane and actin cytoskeleton at the polar cortex and cleavage furrow to promote cortical stability and successful completion of cytokinesis in mammalian cells.

2 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ÖKÖzge Karayel
Özge Karayel
EŞErdem Şanal
Erdem Şanal
SGSven H. Giese
Sven H. Giese
ZKZeynep Cansu Uretmen Kagiali
Zeynep Cansu Uretmen Kagiali
APAyşe Nur Polat
Ayşe Nur Polat
NONurhan Ozlu
Nurhan Ozlu
The successful completion of cytokinesis requires the coordinated activities of diverse cellular components including membranes, cytoskeletal elements and chromosomes that together form partly redundant pathways, depending on the cell type. The biochemical analysis of this process is challenging due to its dynamic and rapid nature. Here, we systematically compared monopolar and bipolar cytokinesis and demonstrated that monopolar cytokinesis is a good surrogate for cytokinesis and it is a well-suited system for global biochemical analysis in mammalian cells. Based on this, we established a phosphoproteomic signature of cytokinesis. More than 10,000 phosphorylation sites were systematically monitored; around 800 of those were up-regulated during cytokinesis. Reconstructing the kinase-substrate interaction network revealed 31 potentially active kinases during cytokinesis. The kinase-substrate network connects proteins between cytoskeleton, membrane and cell cycle machinery. We also found consensus motifs of phosphorylation sites that can serve as biochemical markers specific to cytokinesis. Beyond the kinase-substrate network, our reconstructed signaling network suggests that combination of sumoylation and phosphorylation may regulate monopolar cytokinesis specific signaling pathways. Our analysis provides a systematic approach to the comparison of different cytokinesis types to reveal alternative ways and a global overview, in which conserved genes work together and organize chromatin and cytoplasm during cytokinesis.

25 September 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ISIqra Sohail
Iqra Sohail
SLSuli-Anne Laurin
Suli-Anne Laurin
GKGunnar Kleinau
Gunnar Kleinau
VCVidicha Chunilal
Vidicha Chunilal
AMAndrew Morton
Andrew Morton
HBHeike Biebermann
Heike Biebermann
The melanocortin-4 receptor is a G protein-coupled receptor and a key regulator of appetite and metabolism. It can interact with the melanocortin-receptor accessory protein 2, a single transmembrane helix protein known to interact with several different G protein-coupled receptors. However, the consequences of this interaction are not completely understood. Here we report that co-expression of melanocortin-receptor accessory protein 2 has multiple effects on the melanocortin-4 receptor: it enhances G protein-mediated signaling and simultaneously impairs β-arrestin2 recruitment and, consequently, internalization. In addition, co-expression of melanocortin-receptor accessory protein 2 leads to an increased number of monomers of melanocortin-4 receptor by disrupting receptor oligomers. A structural homology model of the active state melanocortin-4 receptor – melanocortin-receptor accessory protein 2 – Gαs complex suggests interaction sites that are relevant for receptor activation. Our data indicate that melanocortin-receptor accessory protein 2 is an accessory protein that interacts with and influences melanocortin-4 receptor structure, biasing its signaling towards G protein-mediated effects.

4 September 2017 in Proteomics
Verified
Journal Article
Closed access
PDF file
ZKZeynep Cansu Uretmen Kagiali
Zeynep Cansu Uretmen Kagiali
ZCZeynep Cansu
Zeynep Cansu
AŞAydanur Şentürk
Aydanur Şentürk
ÖKÖzkan Küçük
Özkan Küçük
NENazlı Ezgi
Nazlı Ezgi
NONurhan Ozlu
Nurhan Ozlu

Verified
Journal Article
Open access
PDF file
LALarissa Anthofer
Larissa Anthofer
PGPhilipp Gmach
Philipp Gmach
ZKZeynep Cansu Uretmen Kagiali
Zeynep Cansu Uretmen Kagiali
GKGunnar Kleinau
Gunnar Kleinau
JRJonas Rotter
Jonas Rotter
SPSarah Paisdzior
Sarah Paisdzior
The melanocortin-4 receptor (MC4R) is a key player in the hypothalamic leptin–melanocortin pathway that regulates satiety and hunger. MC4R belongs to the G protein-coupled receptors (GPCRs), which are known to form heterodimers with other membrane proteins, potentially modulating receptor function or characteristics. Like MC4R, thyroid hormones (TH) are also essential for energy homeostasis control. TH transport across membranes is facilitated by the monocarboxylate transporter 8 (MCT8), which is also known to form heterodimers with GPCRs. Based on the finding in single-cell RNA-sequencing data that both proteins are simultaneously expressed in hypothalamic neurons, we investigated a putative interplay between MC4R and MCT8. We developed a novel staining protocol utilizing a fluorophore-labeled MC4R ligand and demonstrated a co-localization of MC4R and MCT8 in human brain tissue. Using in vitro assays such as BRET, IP1, and cAMP determination, we found that MCT8 modulates MC4R-mediated phospholipase C activation but not cAMP formation via a direct interaction, an effect that does not require a functional MCT8 as it was not altered by a specific MCT8 inhibitor. This suggests an extended functional spectrum of MCT8 as a GPCR signaling modulator and argues for the investigation of further GPCR-protein interactions with hitherto underrepresented physiological functions.